South Texas Law Firm Assisting Children and Their Families with Anti-depressant-related Birth Defects
The Barrera Law Firm, based in Harlingen, TX, is assisting Texas children who were born with birth defects allegedly due to mothers taking an antidepressant such as Paxil, Zoloft, Lexapro, Wellbutrin, Prozac, Effexor and Celexa during pregnancy.
Harlingen, TX (PRWEB) March 14, 2012
The Barrera Law Firm, based in Harlingen, TX, is assisting Texas children who were born with birth defects due to mothers taking an antidepressant such as Paxil, Zoloft, Lexapro, Wellbutrin, Prozac, Effexor and Celexa during pregnancy. (NEJM, Use of Selective Serotonin-Reuptake Inhibitors in Pregnancy and the Risk of Birth Defects, June 28, 2007; FDA, FDA Drug Safety Communication: Selective serotonin reuptake inhibitor (SSRI) antidepressant use during pregnancy and reports of a rare heart and lung condition in newborn babies, December 14, 2011)
These drugs, usually called SSRIs, have been commonly prescribed to pregnant women and are associated with causing various birth defects in new born children. The most common defects are heart, lung or cranial defects, cleft lip or palate and club foot.
“It is extremely troubling,” stated Ric A. Barrera, head of the firm, “that pregnant women have trusted in the manufacturers of these drugs to provide a safe and tested product only to find out that their children are now paying the heavy price.”
In January 2012 the British Medical Journal published a study, “Expectant mothers on anti-depressants risk newborns with high blood pressure,” showing that infants born to women who were treated with SSRIs in late pregnancy carried twice the increased risk of a specific heart defect than infants born to women not on SSRIs. In fact the study found that: “Mothers who take anti-depressants during pregnancy are more likely to give birth to children with persistent pulmonary hypertension (high blood pressure in the lungs)“¦Persistent pulmonary hypertension is an increase in blood pressure in the lungs leading to shortness of breath and difficulty breathing. It is a rare, but severe disease with strong links to heart failure.” (BMJ, Expectant mothers on anti-depressants risk newborns with high blood pressure, January 12, 2012)
And the FDA, as early as 2005, issued an alert titled “FDA Advising of Risk of Birth Defects with Paxil: Agency Requiring Updated Product Labeling” which warned that “FDA is advising health care professionals to discuss the potential risk of birth defects with patients taking Paxil who plan to become pregnant or are in their first three months of pregnancy.” (FDA, FDA Advising of Risk of Birth Defects with Paxil, Agency Requiring Updated Product Labeling, December 8, 2005)
“It is sometimes difficult for qualified individuals to come forward, but they may be entitled to compensation to offset the costly past and future expenses which can be associated with cases like these,” said Barrera. “The companies involved need to be sent a strong message that their careless and dangerous products will not be tolerated,” he concluded.
Interested parties may contact the firm at (956) 428-2822 or http://www.barrera-lawfirm.com to see if they qualify. The Barrera Law Firm, 1314 E. Harrison, Harlingen, Texas 78550 (956) 428 2822
For the original version on PRWeb visit: http://www.prweb.com/releases/prweb2012/3/prweb9254541.htm